Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Novo vs. KBP: How a $1.3B deal turned into an international legal fight
Venture Capital
Biotech
French antibody biotech draws in $122M for push to clinic
Adcytherix will use the cash to push its lead cancer asset into the clinic, with new drug filings planned by the end of the year.
Darren Incorvaia
Oct 16, 2025 11:19am
Fierce Biotech Fundraising Tracker: Peptilogics, Tubulis & more
Oct 16, 2025 11:18am
Pelage locks in $120M series B for hair growth program
Oct 15, 2025 7:00am
Tubulis touts $361M series C as next-gen ADC data drop nears
Oct 15, 2025 5:01am
Flagship's Lila adds $115M to series A, bringing total to $350M
Oct 14, 2025 11:33am
Kailera raises hefty $600M to take Zepbound rival into ph. 3
Oct 14, 2025 9:20am